{
  "docId": "019de075-3c48-75dd-a16f-ddcce5fecf48",
  "docSlug": "20dccf7a034b09514201ed73755b4bbb",
  "documentTitle": "Absci | Investor Presentation Deck | 48 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 48,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": "The slide highlights the efficacy of the de novo design model by showing a histogram of binding affinities and key performance metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3c48-75dd-a16f-ddcce5fecf48/14",
  "deckHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48",
  "deckJsonHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48.json",
  "deckAnchorHref": "/decks/019de075-3c48-75dd-a16f-ddcce5fecf48#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.55,
        "y": 0.28
      },
      "kind": "chart",
      "text": "Histogram of -log10Kd (M) for designed antibody variants",
      "attrs": null,
      "subkind": "histogram",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00fb8511-21b9-4f7b-9d82-5003452607f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.13,
        "y": 0.5
      },
      "kind": "image",
      "text": "Antibody scaffold sequence diagram",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a08bcff3-e7c2-4696-b183-b28d77ea57ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.55,
        "y": 0.75
      },
      "kind": "list",
      "text": "440,354 antibody variants designed; Approx. 4,000 estimated binders by ACE Assay; 421 confirmed by SPR; 71 exhibit <10 nM affinity; 3 bind tighter than WT trastuzumab",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d43a291-0a50-4f93-8f9f-f372da72aa9b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.04,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "We selected trastuzumab, which binds HER2, as a scaffold to test the HCDR3 predictions. The model is conditioned with HER2 3D structure and trastuzumab scaffold excluding HCDR3 designs.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7272270a-d4f8-4843-8eeb-e4f04f04e97c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.04,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "Any antibody known to bind to HER2 or any homolog (>40% sequence identity or part of the same homologous superfamily) to HER2 is removed",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e262617b-4d63-49c3-81d5-d2b49f61635b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Laboratory validation straight out of the model; 421 designs confirmed by SPR",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "defefa6e-3006-4bd4-9e89-b7a67071215e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.4,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "CASE STUDY: DE NOVO DESIGN IN SILICO",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c907eaad-ff0d-4d2c-8e08-c10f85b38e55",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 48,
      "from": 6,
      "beatId": "7c165ad6-f743-4405-9aff-e111239d7bcd",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 6-48 present Absci's AI-powered solution for biologic drug creation",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}